Proleukin Market Report 2026
Download Free Sample Buy Now
Proleukin Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Proleukin Market Report 2026

Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Proleukin Market Overview

• The Proleukin market growth in the historic period has been driven by approval for cystic fibrosis management, proven mucus thinning efficacy

• Market expansion is supported by rising cf diagnosis rates, improved life expectancy of patients

• Growth Driver: Rising Cancer Incidence Fuels Growth In The Proleukin Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Proleukin Market?

Proleukin is the brand name for aldesleukin, a recombinant form of interleukin-2 (IL-2), a naturally occurring protein in the body. Proleukin is classified as a biologic therapy and is primarily used in oncology and immunotherapy. It works by stimulating the growth and activity of certain white blood cells (lymphocytes), enhancing the immune system's ability to recognize and attack cancer cells.

The main types of proleukin are injection, powder, and others. Proleukin injection is a liquid formulation of aldesleukin, a recombinant interleukin-2 used for immune system modulation. It is used for various clinical indications such as metastatic renal cell carcinoma (RCC), non-small cell lung cancer (NSCLC), other indications, and various therapeutic areas such as oncology, immunology, and others. These are distributed through both online and offline channels. It is applied in hospitals and pharmacies for both adults and pediatrics.

Proleukin Market Global Report 2026 Market Report bar graph

What Is The Proleukin Market Size and Share 2026?

The proleukin market size has grown strongly in recent years. It will grow from $1.24 million in 2025 to $1.32 million in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to approval for cystic fibrosis management, proven mucus thinning efficacy, chronic disease treatment need, hospital respiratory adoption, improved patient outcomes.

What Is The Proleukin Market Growth Forecast?

The proleukin market size is expected to see strong growth in the next few years. It will grow to $1.68 million in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising cf diagnosis rates, improved life expectancy of patients, expansion of homecare therapy use, growth of specialty pharmacies, continued respiratory innovation. Major trends in the forecast period include standard of care in cystic fibrosis treatment, long term use in mucus clearance therapy, home based nebulized treatment adoption, hospital and homecare integration, continued reliance on enzyme therapies.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Proleukin Market Segmentation

1) By Type: Injection, Powder, Other Types

2) By Therapeutic Area: Oncology, Immunology, Other Therapeutic Areas

3) By Clinical Indication: Metastatic Renal Cell Carcinoma (RCC), Non-Small Cell Lung Cancer (NSCLC), Other Indications

4) By Application: Hospital, Pharmacy

5) By End-User: Adults, Pediatrics

What Are The Drivers Of The Proleukin Market?

The growing cancer disease is expected to drive the growth of the proleukin market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells, which can invade nearby tissues and, if untreated, may metastasize to other parts of the body. The increasing prevalence of cancer can be attributed to factors such as an aging population, better detection methods, lifestyle changes, environmental exposures, and improved survival rates, all of which contribute to more people being diagnosed and living with cancer. Proleukin, a high-dose interleukin-2 therapy, helps cancer patients by stimulating the immune system's natural ability to target and destroy cancer cells, offering a potential treatment option for advanced malignancies such as metastatic melanoma and renal cell carcinoma. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, an estimated 20 million new cancer cases and 9.7 million deaths were reported in 2022, with projections suggesting a 77% increase to over 35 million new cases by 2050. Therefore, the growing cancer disease is driving the growth of the proleukin industry.

The increasing research and development activities are expected to drive the growth of the proleukin market going forward. Research and development (R&D) activities involve the systematic investigation and innovation aimed at creating new products, improving existing ones, or developing new technologies and solutions through scientific and technical research. Research and development activities are rising due to the growing demand for innovation, technological advancements, and the need to address emerging global challenges in various industries. Research and development activities positively impact Proleukin by enhancing its efficacy, exploring new cancer indications, improving delivery mechanisms, and potentially reducing side effects, thereby broadening its clinical utility and patient reach. For instance, in February 2025, according to the National Center for Science and Engineering Statistics (NCSES), a US-based government statistical agency, U.S. research and development expenditures rose from $892 billion in 2022 to $940 billion in 2023, reflecting an increase of $48 billion. Therefore, the increasing research and development activities are driving the growth of the proleukin industry.

Key Players In The Global Proleukin Market

Major companies operating in the proleukin market are Novartis Pharmaceuticals Corporation

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Proleukin Market?

In May 2023, Iovance Biotherapeutics, a US-based biotechnology company that develops innovative T-cell-based cancer immunotherapies, acquired Proleukin (aldesleukin) from Clinigen Limited for an undisclosed amount. This acquisition enables Iovance Biotherapeutics to enhance its T-cell-based cancer immunotherapy platform by integrating Proleukin (aldesleukin), a key immunotherapy agent, to improve the effectiveness of its tumor-infiltrating lymphocyte (TIL) therapies, thus advancing its pipeline of innovative cancer treatments and strengthening its position in the competitive oncology market. Clinigen Group is a UK-based company that offers Proleukin (aldesleukin).

Regional Insights

North America was the largest region in the proleukin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Proleukin Market?

The proleukin market consists of sales of cancer vaccines, biosimilars, immune checkpoint inhibitors and adjuvants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Proleukin Market Report 2026?

The proleukin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the proleukin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Proleukin Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $ billion
Revenue Forecast In 2035 $ billion
Growth Rate CAGR of 6.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Therapeutic Area, Clinical Indication, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Novartis Pharmaceuticals Corporation
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Proleukin Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Proleukin Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Proleukin Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Proleukin Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Standard Of Care In Cystic Fibrosis Treatment

4.2.2 Long Term Use In Mucus Clearance Therapy

4.2.3 Home Based Nebulized Treatment Adoption

4.2.4 Hospital And Homecare Integration

4.2.5 Continued Reliance On Enzyme Therapies

5. Proleukin Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Pulmonology Clinics

5.3 Specialty Care Centers

5.4 Homecare Providers

5.5 Pediatric Treatment Centers

6. Proleukin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Proleukin Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Proleukin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Proleukin Market Size, Comparisons And Growth Rate Analysis

7.3. Global Proleukin Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Proleukin Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Proleukin Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Proleukin Market Segmentation

9.1. Global Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injection, Powder, Other Types

9.2. Global Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Immunology, Other Therapeutic Areas

9.3. Global Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Metastatic Renal Cell Carcinoma (RCC), Non-Small Cell Lung Cancer (NSCLC), Other Indications

9.4. Global Proleukin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Pharmacy

9.5. Global Proleukin Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adults, Pediatrics

10. Proleukin Market Regional And Country Analysis

10.1. Global Proleukin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Proleukin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Proleukin Market

11.1. Asia-Pacific Proleukin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Proleukin Market

12.1. China Proleukin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Proleukin Market

13.1. India Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Proleukin Market

14.1. Japan Proleukin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Proleukin Market

15.1. Australia Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. South Korea Proleukin Market

16.1. South Korea Proleukin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

16.2. South Korea Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Western Europe Proleukin Market

17.1. Western Europe Proleukin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. Western Europe Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. UK Proleukin Market

18.1. UK Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Germany Proleukin Market

19.1. Germany Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. France Proleukin Market

20.1. France Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Eastern Europe Proleukin Market

21.1. Eastern Europe Proleukin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Eastern Europe Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. North America Proleukin Market

22.1. North America Proleukin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

22.2. North America Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. USA Proleukin Market

23.1. USA Proleukin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

23.2. USA Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Canada Proleukin Market

24.1. Canada Proleukin Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

24.2. Canada Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. South America Proleukin Market

25.1. South America Proleukin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

25.2. South America Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Middle East Proleukin Market

26.1. Middle East Proleukin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Middle East Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Africa Proleukin Market

27.1. Africa Proleukin Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Africa Proleukin Market, Segmentation By Type, Segmentation By Therapeutic Area, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Proleukin Market Regulatory and Investment Landscape

29. Proleukin Market Competitive Landscape And Company Profiles

29.1. Proleukin Market Competitive Landscape And Market Share 2024

29.1.1. Top 10 Companies (Ranked by revenue/share)

29.2. Proleukin Market - Company Scoring Matrix

29.2.1. Market Revenues

29.2.2. Product Innovation Score

29.2.3. Brand Recognition

29.3. Proleukin Market Company Profiles

29.3.1. Novartis Pharmaceuticals Corporation Overview, Products and Services, Strategy and Financial Analysis

30. Global Proleukin Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Proleukin Market

32. Proleukin Market High Potential Countries, Segments and Strategies

32.1 Proleukin Market In 2030 - Countries Offering Most New Opportunities

32.2 Proleukin Market In 2030 - Segments Offering Most New Opportunities

32.3 Proleukin Market In 2030 - Growth Strategies

32.3.1 Market Trend Based Strategies

32.3.2 Competitor Strategies

33. Appendix

33.1. Abbreviations

33.2. Currencies

33.3. Historic And Forecast Inflation Rates

33.4. Research Inquiries

33.5. The Business Research Company

33.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Proleukin Market, Overview Of Key Products - Product Examples
  • Table 2: Global Proleukin Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Proleukin Market, Supply Chain Analysis
  • Table 4: Global Proleukin Market, Major Raw Material Providers
  • Table 5: Global Proleukin Market, Major Resource Providers
  • Table 6: Global Proleukin Market, Major Manufacturers (Suppliers)
  • Table 7: Global Proleukin Market, Major Distributors And Channel Partners
  • Table 8: Global Proleukin Market, Key Technologies & Future Trends
  • Table 9: Global Proleukin Market, Major Trends
  • Table 10: Global Proleukin Market, Major End Users
  • Table 11: Global Proleukin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Proleukin Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Proleukin Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Proleukin Market - TAM, US$ Billion, 2025
  • Table 15: Global Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Proleukin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Proleukin Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Proleukin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Proleukin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: South Korea, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: South Korea, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Western Europe, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Western Europe, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Western Europe, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: UK, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: UK, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: UK, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Germany, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Germany, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Germany, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: France, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: France, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: France, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Eastern Europe, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Eastern Europe, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Eastern Europe, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: North America, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: North America, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: North America, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: USA, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: USA, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: USA, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Canada, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Canada, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Canada, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: South America, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: South America, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: South America, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Middle East, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Middle East, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Middle East, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Africa, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Africa, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Africa, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Global Proleukin Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 74: Global Proleukin Market - Company Scoring Matrix
  • Table 75: Novartis Pharmaceuticals Corporation Financial Performance
  • Table 76: Global Proleukin Market, Competitive Benchmarking (In USD Billions)
  • Table 77: Global Proleukin Market, Competitive Dashboard
  • Table 78: Global Proleukin Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 79: Global, Proleukin Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 80: Global, Proleukin Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030
  • Table 81: Global, Proleukin Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

List Of Figures

    Figure 1: Global Proleukin Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Proleukin Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Proleukin Market, Supply Chain Analysis
  • Figure 4: Global Proleukin Market, Major Raw Material Providers
  • Figure 5: Global Proleukin Market, Major Resource Providers
  • Figure 6: Global Proleukin Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Proleukin Market, Major Distributors And Channel Partners
  • Figure 8: Global Proleukin Market, Key Technologies & Future Trends
  • Figure 9: Global Proleukin Market, Major Trends
  • Figure 10: Global Proleukin Market, Major End Users
  • Figure 11: Global Proleukin Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Proleukin Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Proleukin Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Proleukin Market - TAM, US$ Billion, 2025
  • Figure 15: Global Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Proleukin Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Proleukin Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Proleukin Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Proleukin Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: South Korea, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: South Korea, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Western Europe, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Western Europe, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Western Europe, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: UK, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: UK, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: UK, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Germany, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Germany, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Germany, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: France, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: France, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: France, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Eastern Europe, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Eastern Europe, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Eastern Europe, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: North America, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: North America, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: North America, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: USA, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: USA, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: USA, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Canada, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Canada, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Canada, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: South America, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: South America, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: South America, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Middle East, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Middle East, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Middle East, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Africa, Proleukin Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Africa, Proleukin Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Africa, Proleukin Market, Segmentation By Clinical Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Global Proleukin Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 74: Global Proleukin Market - Company Scoring Matrix
  • Figure 75: Novartis Pharmaceuticals Corporation Financial Performance
  • Figure 76: Global Proleukin Market, Competitive Benchmarking (In USD Billions)
  • Figure 77: Global Proleukin Market, Competitive Dashboard
  • Figure 78: Global Proleukin Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 79: Global, Proleukin Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 80: Global, Proleukin Market Size Gain ($ Billion), Segmentation By Therapeutic Area, 2025 – 2030
  • Figure 81: Global, Proleukin Market Size Gain ($ Billion), Segmentation By Clinical Indication, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Rare Inflammatory Disease Treatment Market Report 2026 - Global Outlook – By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectables, Oral, Other Administration Modes), By Indication (Ulcerative...

Anti-Inflammatory Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics), By Indication (Arthritis, Respiratory Dise...

Immune Health Supplements Market Report 2026 - Global Outlook – By Ingredients Type (Vitamins, Minerals, Herbal Botanical Extracts, Probiotics, Amino Acids, Omega 3 - Fatty Acids), By Form (Soft Gels Or Capsules, Tablets...

Immunotoxin Market Report 2026 - Global Outlook – By Type (Anthrax Based Toxins, Diphtheria Toxin (DT) And Derivatives, Pseudomonas Exotoxin (PE) And Derivatives, Ribosome Inactivating Proteins Based Immunotoxins, Ribonu...

Non-Steroidal Anti-inflammatory Drugs Market Report 2026 - Global Outlook – By Route Of Administration (Oral, Topical, Other Route Of Administration), By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, Othe...

Immunomodulator Market Report 2026 - Global Outlook – By Product Type (Immunosuppressants, Immunostimulants, Other Product Types), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distr...

Therapeutic Plasma Exchange Market Report 2026 - Global Outlook – By Type (Therapeutic Plasma Exchange (TPE), Double Filtered Plasmapheresis (DFPP)), By Indication (Neurological Disorders, Hematological Disorders, Renal ...

Immunoassay Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Mon...

Frequently Asked Questions

The Proleukin market was valued at $ billion in 2025, increased to $ billion in 2026, and is projected to reach $ billion by 2030.

The global Proleukin market is expected to grow at a CAGR of 6.1% from 2026 to 2035 to reach $ billion by 2035.

Some Key Players in the Proleukin market Include, Novartis Pharmaceuticals Corporation .

Major trend in this market includes: nan. For further insights on this market. request a sample here

North America was the largest region in the proleukin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the proleukin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us